Cuprous chloride

We are Cuprous chloride CAS: 7758-89-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Other name: 
Cuprous Chloride
Copper (I) chloride

 

CAS No.: 7758-89-6

Molecular Weight: 98.99
 

Characters: White crystalline powder, can be easily oxidized into green highcopper salts in humid air; will be decomposed when exposed to light and turn brown, soluble in acids and ammonia water insoluble in water and alcohols.
 

Specifications:

Cuprous chloride	High-puritySpecial-purpose grade	Reagent grade A.R.	Reagent grade C.P.	Technical first grade	Technical second grade
Item	Spec.	Spec.	Spec.	Spec.	Spec.
Assay(CuCl) %	≥99.0	≥99.0	≥98.0	≥99.0	≥98.0
Highcopper salts(CuCl2)%	≤0.5	—	—	≤0.8	≤1.0
Insol. in acids %	≤0.01	≤0.01	≤0.03	≤0.1	≤0.1
Sulphates(asSO4)%	≤0.2	≤0.2	≤0.4	≤0.05	≤0.1
Fe%	≤0.005	≤0.002	≤0.005	≤0.005	≤0.005
As%?/DIV>	—	≤0.0005	≤0.002	—	—
Non-precipitate in sulfureted hydrogen(asSO4)%	—	≤0.15	≤0.30	—	—
Fineness(60-mesh sieve residue) %	—	—	—	—	≤5

Product Usage: Used as catalyst for organic synthesis, as chemical reagent, pharmacy, pesticides, petroleum desulfurization etc.

Packaging: 25kg woven bag or cardboard drum lined with black plastic bag.

Storage Precautions: Avoid light; stored in cool, dry and draughty warehouse.

Related News: How can I protect myself? Take the same precautionary measures you would during flu season. Wash your hands often with soap and water, cover your nose and mouth when you sneeze or cough, avoid close contact with people or large gatherings, and wear a face mask.4,4'-Diisocyanato-3,3'-dimethyl-1,1'-biphenyl CAS:91-97-4 How can I protect myself? Take the same precautionary measures you would during flu season. Wash your hands often with soap and water, cover your nose and mouth when you sneeze or cough, avoid close contact with people or large gatherings, and wear a face mask.4- (2-bromoacetil) benzonitrilo CAS:20099-89-2 Advanced clinical trials with the Company’s lead compound, rigosertib, are aimed at what the Company believes are unmet medical needs of patients with MDS.154212-61-0 It is delivered to hospitals and pharmacies until it reaches the patient.At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.